טוען...
miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells
Nintedanib (BIBF1120) is a multi-targeted angiokinase inhibitor and has been evaluated in idiopathic pulmonary fibrosis and advanced non-small cell lung cancer (NSCLC) patients in clinical studies. In the present study, we evaluated the antitumor effects of nintedanib in 16 NSCLC cell lines and trie...
שמור ב:
| הוצא לאור ב: | Int J Oncol |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
D.A. Spandidos
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4750530/ https://ncbi.nlm.nih.gov/pubmed/26783187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2016.3331 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|